Sarepta Therapeutics Shares Surge on Analyst Optimism
Published on 10/03/2025 at 14:00 | Redaktion boerse-global.de
Sarepta Therapeutics witnessed a dramatic trading session as its stock price jumped more than 10%, closing at $21.32 before extending gains in after-hours activity. This powerful upward movement stems from recent analyst upgrades and continued momentum following the company’s impressive quarterly earnings report.
The biotechnology firm’s fundamental results provided a solid foundation for the market enthusiasm. Sarepta reported quarterly earnings of $2.02 per share, substantially exceeding analyst projections of $0.89. Revenue reached $611 million, surpassing estimates by $80 million and representing impressive year-over-year growth of 68.4%.
Wall Street Support Builds Momentum
Multiple financial institutions have revised their outlook on Sarepta, contributing to the positive sentiment. Oppenheimer upgraded the stock to “Outperform” with a price target of $37. This bullish assessment was echoed by... Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
